BRENTWOOD, Tenn., Oct. 10, 2022 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a number one short-stay surgical facility proprietor and operator, introduced the Company will launch its third quarter 2022 outcomes earlier than the market opens on Tuesday, November 8, 2022, to be adopted by a convention name at 8:30 a.m. (Eastern Time)
You can be a part of the decision as follows:
- Dial in quantity for stay entry: 1-877-451-6152 (home), 1-201-389-0879 (worldwide)
- Replay (out there 3 hours after the decision and out there till November 22, 2022): 1-844-512-2921 (home), 1-412-317-6671 (worldwide)
- Passcode for the stay name and the replay: 13732757
Interested buyers and different events can also hearken to a simultaneous webcast of the convention name by logging onto the Investor Relations part of the Company’s web site at www.surgerypartners.com. The replay can even be out there on this similar web site for a restricted time following the decision.
To study extra about Surgery Partners, please go to the corporate’s web site at www.surgerypartners.com. Surgery Partners makes use of its web site as a channel of distribution of fabric firm data. Financial and different materials data relating to Surgery Partners is routinely posted on the Company’s web site and is instantly accessible.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a number one healthcare providers firm with a differentiated outpatient supply mannequin centered on offering high-quality, cost-effective options for surgical and associated ancillary care in assist of each sufferers and physicians. Founded in 2004, Surgery Partners is likely one of the largest and quickest rising surgical providers companies within the nation, with greater than 180 places in 32 states, together with ambulatory surgical procedure facilities, surgical hospitals, multi-specialty doctor practices and pressing care services. For extra data, go to www.surgerypartners.com.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
[email protected]
